Generation Bio Ownership | Who Owns Generation Bio?
Generation Bio Ownership Summary
Generation Bio is owned by 19.32% institutional investors, 14.40% insiders, and 66.28% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 13.90% of GBIO shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 7.99% of its assets in Generation Bio shares.
GBIO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Generation Bio | 19.32% | 14.40% | 66.28% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Price t rowe associates inc /md/ | 9.28M | 13.90% | $9.84M |
Atlas venture life science advisors | 8.28M | 12.41% | $8.78M |
Fmr | 4.63M | 6.93% | $4.90M |
Blackrock funding, inc. /de | 3.46M | 5.18% | $3.67M |
Blackrock | 3.29M | 4.96% | $9.29M |
Bank of america corp /de/ | 2.98M | 4.49% | $8.41M |
Siren | 2.98M | 4.47% | $3.16M |
Artal group | 2.83M | 4.26% | $7.98M |
Vanguard group | 2.64M | 3.96% | $2.80M |
Jefferies financial group | 2.26M | 3.39% | $2.40M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Atlas venture life science advisors | 8.28M | 1.07% | $8.78M |
Artal group | 2.83M | 0.20% | $7.98M |
Siren | 2.98M | 0.14% | $3.16M |
Ecor1 capital | 2.05M | 0.08% | $2.17M |
Pfm health sciences, lp | 787.91K | 0.05% | $835.19K |
Palo alto investors lp | 150.47K | 0.02% | $159.50K |
Baker bros. advisors lp | 1.94M | 0.02% | $2.06M |
Jefferies financial group | 2.26M | 0.01% | $2.40M |
Yiheng capital management | 191.53K | 0.01% | $203.02K |
Bridgeway capital management | 246.80K | 0.01% | $261.61K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Jefferies financial group | 2.26M | 0.01% | 2.26M |
Renaissance | 962.96K | 0.00% | 368.66K |
Jacobs levy equity management | 301.05K | 0.00% | 268.70K |
Blackrock | 3.29M | 0.00% | 245.40K |
Ubs group | 1.05M | 0.00% | 206.62K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bellevue group | - | - | -3.92M |
Fmr | 4.63M | 0.00% | -694.22K |
D. e. shaw | 344.92K | 0.00% | -143.23K |
Bridgeway capital management | 246.80K | 0.01% | -77.20K |
Price t rowe associates inc /md/ | 9.28M | 0.00% | -72.53K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Jefferies financial group | 2.26M | 0.01% | 2.26M | $2.40M |
Wellington management group llp | 119.36K | 0.00% | 119.36K | $336.58K |
Integrated wealth concepts | 72.72K | 0.00% | 72.72K | $77.08K |
Squarepoint ops | 65.63K | 0.00% | 65.63K | $69.57K |
Intech investment management | 23.34K | 0.00% | 23.34K | $24.74K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -9.00 |
Srs capital advisors | -38.00 |
Capital performance advisors llp | -45.00 |
Gamma investing | -50.00 |
Point72 (difc) | -218.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 20 | -73.33% | 12,890,700 | -76.66% | 19 | 0.28% | 7 | -73.08% | 5 | -81.48% |
Sep 30, 2024 | 75 | -3.85% | 55,236,045 | -0.45% | 82 | 1.19% | 26 | -36.59% | 27 | 17.39% |
Jun 30, 2024 | 77 | - | 55,483,273 | 0.97% | 83 | 1.21% | 41 | 10.81% | 23 | -14.81% |
Mar 31, 2024 | 77 | - | 54,950,287 | 4.52% | 83 | 1.31% | 37 | -27.45% | 27 | 80.00% |
Dec 31, 2023 | 77 | -2.53% | 52,571,581 | -8.10% | 79 | 1.05% | 51 | 82.14% | 15 | -42.31% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
US Small-Cap Growth II Equity Comp | 5.34M | 7.99% | -4.59K |
T. Rowe Price New Horizons | 5.34M | 7.96% | - |
BB Biotech AG Ord | 3.92M | 5.87% | - |
Fidelity Growth Compy Commingled Pl S | 2.00M | 2.99% | 3.35K |
Fidelity Growth Compy Commingled Pl O | 1.94M | 2.91% | - |
Fidelity Growth Company Fund | 1.77M | 2.65% | - |
Vanguard Total Stock Mkt Idx Inv | 1.56M | 2.32% | - |
Vanguard US Total Market Shares ETF | 1.56M | 2.32% | - |
T. Rowe Price Health Sciences | 1.55M | 2.31% | - |
iShares Russell 2000 ETF | 1.27M | 1.90% | -11.05K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 10, 2025 | Quinn Anthony G. | - | Buy | $120.76K |
Jan 13, 2025 | Quinn Anthony G. | - | Buy | $82.45K |
Jul 01, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $18.41K |
Jan 02, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $3.96K |
Jan 02, 2024 | Samayoa Phillip | CHIEF STRATEGY OFFICER | Sell | $3.96K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 2 | - |
2024 Q4 | - | - |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | 2 |
GBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools